Erik Sahai, Hongxia Wang, Marleen Kok, Catherine J. Wu, Lin Shen, John Carpten, César Serrano, Varun Venkataramani
{"title":"许多途径,一个目标:弥合癌症治疗的差距","authors":"Erik Sahai, Hongxia Wang, Marleen Kok, Catherine J. Wu, Lin Shen, John Carpten, César Serrano, Varun Venkataramani","doi":"10.1016/j.ccell.2025.03.026","DOIUrl":null,"url":null,"abstract":"This special issue of <em>Cancer Cell</em> is dedicated to “bridging the gap between foundational cancer biology and clinical oncology.” We asked scientists and clinicians to give us a brief “state of the field,” discussing the integration of new technologies, the importance of patient-centric approaches, the need for innovative clinical trial designs, and how fostering teamwork and inclusive research can help us bridge the gap between cancer research and effective clinical applications.","PeriodicalId":9670,"journal":{"name":"Cancer Cell","volume":"137 1","pages":""},"PeriodicalIF":48.8000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Many paths, one destination: Bridging the gap in cancer care\",\"authors\":\"Erik Sahai, Hongxia Wang, Marleen Kok, Catherine J. Wu, Lin Shen, John Carpten, César Serrano, Varun Venkataramani\",\"doi\":\"10.1016/j.ccell.2025.03.026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This special issue of <em>Cancer Cell</em> is dedicated to “bridging the gap between foundational cancer biology and clinical oncology.” We asked scientists and clinicians to give us a brief “state of the field,” discussing the integration of new technologies, the importance of patient-centric approaches, the need for innovative clinical trial designs, and how fostering teamwork and inclusive research can help us bridge the gap between cancer research and effective clinical applications.\",\"PeriodicalId\":9670,\"journal\":{\"name\":\"Cancer Cell\",\"volume\":\"137 1\",\"pages\":\"\"},\"PeriodicalIF\":48.8000,\"publicationDate\":\"2025-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Cell\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ccell.2025.03.026\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Cell","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ccell.2025.03.026","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
Many paths, one destination: Bridging the gap in cancer care
This special issue of Cancer Cell is dedicated to “bridging the gap between foundational cancer biology and clinical oncology.” We asked scientists and clinicians to give us a brief “state of the field,” discussing the integration of new technologies, the importance of patient-centric approaches, the need for innovative clinical trial designs, and how fostering teamwork and inclusive research can help us bridge the gap between cancer research and effective clinical applications.
期刊介绍:
Cancer Cell is a journal that focuses on promoting major advances in cancer research and oncology. The primary criteria for considering manuscripts are as follows:
Major advances: Manuscripts should provide significant advancements in answering important questions related to naturally occurring cancers.
Translational research: The journal welcomes translational research, which involves the application of basic scientific findings to human health and clinical practice.
Clinical investigations: Cancer Cell is interested in publishing clinical investigations that contribute to establishing new paradigms in the treatment, diagnosis, or prevention of cancers.
Insights into cancer biology: The journal values clinical investigations that provide important insights into cancer biology beyond what has been revealed by preclinical studies.
Mechanism-based proof-of-principle studies: Cancer Cell encourages the publication of mechanism-based proof-of-principle clinical studies, which demonstrate the feasibility of a specific therapeutic approach or diagnostic test.